Immunohistochemistry

Book an Appointment

For prices please call us on 09158585888, 07038642919. Or send us an email at info@buntaimedicaldiagnostics.com

Breast Cancer Markers	Routine/Non-Routine Test	Sample Required	IVD Platform	Relevance	Sample Collection Kit	Turn Around Time
ER	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
PR	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
HER2	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
PDL1	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
E-CADHERIN	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
Mammaglobin	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days

Hematological Markers	Routine/Non-Routine Test	Sample Required	IVD Platform	Relevance	Sample Collection Kit	Turn Around Time
Lymphocyte	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CD45	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CD3	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CD5	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CD20	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CD23	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CD10	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CyclinD1	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
BCL2	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CD79a	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
TdT/CD34	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CD30	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CD15	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days

Lung Markers	Routine/Non-Routine Test	Sample Required	IVD Platform	Relevance	Sample Collection Kit	Turn Around Time
EGFR	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
ALK	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
NRAS	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
PDL1	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
Napsin A	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
TTF-1	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days

Neuroendocrine Markers	Routine/Non-Routine Test	Sample Required	IVD Platform	Relevance	Sample Collection Kit	Turn Around Time
Synaptophysin	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
Chromogranin A	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days

Epithelial Markers	Routine/Non-Routine Test	Sample Required	IVD Platform	Relevance	Sample Collection Kit	Turn Around Time
CK18	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CK20	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CK7	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CK5/6	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
AE1/AE3	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
EMA	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days

Soft Tissue Markers	Routine/Non-Routine Test	Sample Required	IVD Platform	Relevance	Sample Collection Kit	Turn Around Time
Vimentin	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
Desmin	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
SMA	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
MDM2	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
Beta catenin	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days

Other Markers	Routine/Non-Routine Test	Sample Required	IVD Platform	Relevance	Sample Collection Kit	Turn Around Time
TFE3	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
MUC4	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
P16	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CDX2	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
TLE1	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
GFAP	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
NSE	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
AMACR	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
KRAS	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
KI67	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
AFP	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CD117	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CEA	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CA125	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CA15-3	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CA19-9	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CA72-4	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
S100	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
HMB45	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
Thyroglobin	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
P63	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
HEPAR1	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
KL67	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CD99	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
CD34	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
HER2	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
MLH1	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
MSH6	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days
PMS2	Non-Routine	FFPE	Histology and Immunohisto-chemistry	Diagnosis and treatment monitoring as well as prognosis of multiple cancers	N/A	5 working days

***Kindly note that all anatomic pathology cases for second opinion will not follow the routine TAT, and they will be determined by the consultant anatomic pathologist in charge of the case(s).

Lagos Office

Osogbo Office